Kenichi Mishima Selected Research

6- (1H- imidazol- 1- yl)- 7- nitro- 2,3(1H,4H)- quinoxalinedione

1/2004

Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenichi Mishima Research Topics

Disease

35	Brain Ischemia (Cerebral Ischemia) 01/2022 - 01/2003
18	Ischemia 12/2012 - 12/2002
14	Infarction (Infarctions) 01/2022 - 10/2004
11	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 12/2002
10	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 12/2003
10	Dementia (Dementias) 05/2018 - 10/2003
7	Cerebral Infarction 09/2009 - 01/2003
6	Inflammation (Inflammations) 03/2022 - 03/2005
6	Ischemic Stroke 01/2022 - 07/2010
6	Brain Injuries (Brain Injury) 01/2020 - 03/2008
6	Achondroplasia 01/2020 - 01/2013
6	Memory Disorders (Memory Loss) 08/2012 - 01/2006
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2012 - 12/2002
6	Hypoxia (Hypoxemia) 11/2005 - 10/2002
5	Catalepsy 01/2020 - 11/2006
5	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 09/2008 - 10/2005
4	Infections 07/2020 - 03/2005
4	Stroke (Strokes) 12/2012 - 04/2010
4	Amyloid Plaque 07/2010 - 05/2005
3	Legg-Calve-Perthes Disease (Perthes Disease) 05/2022 - 09/2013
3	Congenital Abnormalities (Deformity) 07/2020 - 11/2013
3	Motion Sickness (Airsickness) 01/2017 - 01/2013
3	Hypertension (High Blood Pressure) 04/2012 - 09/2010
3	Hypothermia 01/2008 - 05/2004
3	Tremor (Tremors) 01/2008 - 01/2006
2	Cerebral Hemorrhage 01/2022 - 10/2015
2	Brain Edema (Cerebral Edema) 01/2022 - 03/2018
2	Neoplasms (Cancer) 07/2020 - 07/2017
2	Hypersensitivity (Allergy) 01/2019 - 06/2018
2	Slipped Capital Femoral Epiphyses 05/2017 - 11/2013
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 08/2016 - 01/2014
2	Hemorrhage 03/2016 - 10/2015
2	Cleidocranial Dysplasia (Cleidocranial Dysostosis) 02/2015 - 01/2014
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2013 - 07/2012
2	Cognitive Dysfunction 02/2008 - 01/2006
1	Necrosis 05/2022

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2017 - 03/2005
11	HMGB1 Protein (HMG1)IBA 01/2022 - 03/2008
11	Dronabinol (THC)FDA LinkGeneric 01/2020 - 10/2004
9	Neuroprotective AgentsIBA 01/2011 - 10/2003
8	CannabidiolIBA 07/2010 - 10/2004
7	Amyloid beta-PeptidesIBA 07/2013 - 12/2002
6	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2020 - 01/2013
6	Cholinergic Agents (Cholinergics)IBA 01/2019 - 02/2007
6	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2009 - 12/2002
5	Yi-Gan SanIBA 03/2014 - 03/2009
4	Meclizine (Meclozine)FDA LinkGeneric 01/2020 - 01/2013
3	Muscarinic M1 ReceptorIBA 01/2019 - 01/2006
3	Haloperidol (Haldol)FDA LinkGeneric 12/2017 - 10/2005
3	TeicoplaninIBA 01/2017 - 01/2014
3	von Willebrand FactorIBA 10/2015 - 02/2010
3	Telmisartan (Micardis)FDA Link 01/2012 - 10/2009
3	Glutamic Acid (Glutamate)FDA Link 04/2010 - 04/2004
3	5-HT1A Serotonin ReceptorIBA 09/2008 - 10/2005
3	Scopolamine (Hyoscine)FDA Link 01/2008 - 01/2005
3	theanineIBA 01/2008 - 06/2004
3	OxotremorineIBA 01/2008 - 01/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2013
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 10/2015
2	Therapeutic UsesIBA 01/2022 - 03/2019
2	InterleukinsIBA 01/2022 - 11/2014
2	CytokinesIBA 01/2022 - 07/2020
2	Serine (L-Serine)FDA Link 11/2021 - 05/2018
2	SynucleinsIBA 11/2021 - 05/2018
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019 - 01/2005
2	Messenger RNA (mRNA)IBA 07/2017 - 01/2005
2	Transcription Factors (Transcription Factor)IBA 02/2015 - 01/2014
2	Dynamin IIBA 07/2013 - 07/2010
2	Protein Isoforms (Isoforms)IBA 12/2012 - 01/2003
2	Peroxidase (Myeloperoxidase)IBA 10/2012 - 12/2008
2	Type 1 Angiotensin ReceptorIBA 01/2012 - 09/2010
2	Amyloid (Amyloid Fibrils)IBA 01/2012 - 12/2003
2	Donepezil (Aricept)FDA LinkGeneric 01/2011 - 06/2006
2	PPAR gammaIBA 09/2010 - 10/2009
2	SynaptophysinIBA 07/2010 - 04/2010
2	Proteins (Proteins, Gene)FDA Link 07/2010 - 12/2003
2	Kangen-karyuIBA 04/2010 - 03/2009
2	Antipsychotic Agents (Antipsychotics)IBA 09/2008 - 10/2005
2	Olanzapine (Zyprexa)FDA Link 09/2008 - 02/2008
2	Amlodipine (Norvasc)FDA LinkGeneric 04/2007 - 10/2003
2	nilvadipine (Escor)IBA 04/2007 - 10/2003
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 03/2007 - 10/2004
2	AMPA Receptors (AMPA Receptor)IBA 01/2007 - 01/2005
2	LipopolysaccharidesIBA 03/2005 - 12/2004
2	N-Methylaspartate (NMDA)IBA 01/2004 - 12/2002
1	Indicators and Reagents (Reagents)IBA 03/2022
1	HaptoglobinsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 11/2021
1	Casein Kinase II (Casein Kinase 2)IBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021

Therapy/Procedure

5	Osteotomy 05/2022 - 11/2013
4	Therapeutics 07/2017 - 03/2005
3	External Fixators 07/2020 - 11/2013
3	Ligation 01/2019 - 05/2004
3	Oral Administration 11/2014 - 04/2010
2	Transplantation 07/2020 - 10/2013
2	Operative Time 07/2020 - 11/2013
2	Bone Lengthening 01/2018 - 05/2016
2	Traction 05/2017 - 09/2013